180 related articles for article (PubMed ID: 18676768)
21. Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer.
Barnes NL; Warnberg F; Farnie G; White D; Jiang W; Anderson E; Bundred NJ
Br J Cancer; 2007 Feb; 96(4):575-82. PubMed ID: 17285134
[TBL] [Abstract][Full Text] [Related]
22. Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo.
Xu XF; Xie CG; Wang XP; Liu J; Yu YC; Hu HL; Guo CY
Tohoku J Exp Med; 2008 Jun; 215(2):149-57. PubMed ID: 18577844
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 inhibition as a strategy for treating gastric adenocarcinoma.
Xiang HG; Xie X; Hu FQ; Xiao HB; Zhang WJ; Chen L
Oncol Rep; 2014 Sep; 32(3):1140-8. PubMed ID: 24992958
[TBL] [Abstract][Full Text] [Related]
24. Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines.
Bocca C; Bozzo F; Bassignana A; Miglietta A
Mol Cell Biochem; 2011 Apr; 350(1-2):59-70. PubMed ID: 21140284
[TBL] [Abstract][Full Text] [Related]
25. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia.
Farooqui M; Li Y; Rogers T; Poonawala T; Griffin RJ; Song CW; Gupta K
Br J Cancer; 2007 Dec; 97(11):1523-31. PubMed ID: 17971769
[TBL] [Abstract][Full Text] [Related]
26. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo.
Rahman M; Selvarajan K; Hasan MR; Chan AP; Jin C; Kim J; Chan SK; Le ND; Kim YB; Tai IT
Neoplasia; 2012 Jul; 14(7):624-33. PubMed ID: 22904679
[TBL] [Abstract][Full Text] [Related]
28. Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice.
Wong TY; Li F; Lin SM; Chan FL; Chen S; Leung LK
BMC Cancer; 2014 Jun; 14():426. PubMed ID: 24923427
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
Cui W; Yu CH; Hu KQ
Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255
[TBL] [Abstract][Full Text] [Related]
30. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors.
Saito T; Tamura D; Asano R
Oncol Rep; 2014 Apr; 31(4):1637-44. PubMed ID: 24503782
[TBL] [Abstract][Full Text] [Related]
32. Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor-γ system in experimental rat Barrett's esophagus.
Majka J; Wierdak M; Szlachcic A; Magierowski M; Targosz A; Urbanczyk K; Krzysiek-Maczka G; Ptak-Belowska A; Bakalarz D; Magierowska K; Chmura A; Brzozowski T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G375-G389. PubMed ID: 31928220
[TBL] [Abstract][Full Text] [Related]
33. Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination.
Bhattacharya A; Li Y; Shi Y; Zhang Y
Carcinogenesis; 2013 Nov; 34(11):2593-9. PubMed ID: 23946495
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
[TBL] [Abstract][Full Text] [Related]
35. Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo.
Klenke FM; Abdollahi A; Bischof M; Gebhard MM; Ewerbeck V; Huber PE; Sckell A
Strahlenther Onkol; 2011 Jan; 187(1):45-51. PubMed ID: 21234531
[TBL] [Abstract][Full Text] [Related]
36. Interferon-α and cyclooxygenase-2 inhibitor cooperatively mediates TRAIL-induced apoptosis in hepatocellular carcinoma.
Zuo C; Qiu X; Liu N; Yang D; Xia M; Liu J; Wang X; Zhu H; Xie H; Dan H; Li Q; Wu Q; Burns M; Liu C
Exp Cell Res; 2015 May; 333(2):316-326. PubMed ID: 25724899
[TBL] [Abstract][Full Text] [Related]
37. Antitumor properties of taxol in combination with cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian tumor growth in vivo.
Li W; Zhai L; Tang Y; Cai J; Liu M; Zhang J
Oncol Res; 2012; 20(2-3):49-59. PubMed ID: 23193911
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
[TBL] [Abstract][Full Text] [Related]
39. Preliminary evaluation of anticancer efficacy of pioglitazone combined with celecoxib for the treatment of non-small cell lung cancer.
Kiran AVVVR; Kumari GK; Krishnamurthy PT
Invest New Drugs; 2022 Feb; 40(1):1-9. PubMed ID: 34341904
[TBL] [Abstract][Full Text] [Related]
40. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ
Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
